Laurence Albiges, MD, PhD discusses biomarker studies as well as new combinations and therapies that were presented at the KCRS23 meeting.
Dr. Albiges is a medical oncologist at Gustave Roussy focused on renal cell carcinoma.
Laurence Albiges, MD, PhD discusses biomarker studies as well as new combinations and therapies that were presented at the KCRS23 meeting.
Dr. Albiges is a medical oncologist at Gustave Roussy focused on renal cell carcinoma.